Sign in
4

Changes in Ownership

SAB Biotherapeutics, Inc. Filed Acc 0001209191-22-049168

CHIEF EXECUTIVE OFFICER bought 14,000 shares at $0.74 ($10,315)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Sullivan Eddie Joe CHIEF EXECUTIVE OFFICER 2022-09-07 Purchase +14,000 $0.74 $10,315 5,230,564 D
Open-market purchases · 14,000 sh · avg $0.74 · $10,315
Loading xslF345X03/doc4.xml…